Massa E, Michailidou E, Papadopoulos S, Agapakis D, Kotsamidi I, Xarisopoulos D, Iosifidis E, Daoudaki M, Philis D, Imvrios G, Vagdatli E, Vasilakos D, Papanikolaou V, Fouzas I, Mouloudi E
Intensive Care Unit, Hippokratio General Hospital, Thessaloniki, Greece.
Intensive Care Unit, Hippokratio General Hospital, Thessaloniki, Greece.
Transplant Proc. 2019 Mar;51(2):457-460. doi: 10.1016/j.transproceed.2019.01.077. Epub 2019 Jan 28.
The importance of preoperative donor/recipient colonization or donor infection by extensively drug-resistant Gram-negative bacteria (XDR-GNB) and its relation to serious post-transplantation infection pathogenicity in liver transplantation (LT) patients has not been clarified.
Prevention of postoperative infection due to XDR-GNB with the appropriate perioperative chemoprophylaxis or treatment based on preoperative donor/recipient surveillance cultures in LT patients, as well as their outcome.
Twenty-six patients (20 male, 6 female) were studied (average preoperative Model for End-Stage Liver Disease score ≈15, range: 8-29) from January 2017 to January 2018. In all patients, blood, urine, and bronchial secretions culture samples as well as a rectal colonization culture were taken pre- and postoperatively, once weekly after LT, and after intensive care unit discharge. Recipients with positive XDR-GNB colonization and patients receiving a transplant from a donor with an XDR-GNB positive culture or colonization received the appropriate chemoprophylaxis one half hour preoperatively according to culture results. De-escalation of the antibiotic regimen was done in 2 to 5 days based on the colonization/culture results of the donor and recipient and their clinical condition. Evaluation for serious infection was done at 1 week and at 28 days for outcome results.
Fourteen out of 26 recipients (53.8%) were positive for XDR-GNB colonization preoperative, with 2/14 (14.28%) presenting serious infection due to the same pathogen. Intensive care unit length of stay was significantly longer in colonized with XDR-GNB patients (P < .0001). The outcome of colonized patients was 6/14 (42.8%) expired, but only in 2/14 (14.2%) was mortality attributable to infection.
Administering appropriate perioperative chemoprophylaxis and treatment may limit the frequency of XDR-GNB infections and intensive care unit length of stay and may improve the outcome in LT recipients.
术前供体/受体被广泛耐药革兰氏阴性菌(XDR-GNB)定植或供体感染的重要性及其与肝移植(LT)患者移植后严重感染致病性的关系尚未明确。
通过对LT患者进行适当的围手术期化学预防或基于术前供体/受体监测培养的治疗,预防XDR-GNB引起的术后感染及其结局。
对2017年1月至2018年1月期间的26例患者(20例男性,6例女性)进行研究(术前终末期肝病模型评分平均约为15,范围:8 - 29)。所有患者在术前、术后、LT术后每周一次以及重症监护病房出院后均采集血液、尿液和支气管分泌物培养样本以及直肠定植培养样本。XDR-GNB定植阳性的受体以及接受来自XDR-GNB培养或定植阳性供体移植的患者,根据培养结果在术前半小时接受适当的化学预防。根据供体和受体的定植/培养结果及其临床状况,在2至5天内进行抗生素方案的降阶梯治疗。在1周和第28天对严重感染进行评估以得出结局结果。
26例受体中有14例(53.8%)术前XDR-GNB定植阳性,其中2/14(14.28%)因相同病原体出现严重感染。XDR-GNB定植患者的重症监护病房住院时间明显更长(P <.0001)。定植患者的结局为6/14(42.8%)死亡,但仅2/14(14.2%)的死亡归因于感染。
给予适当的围手术期化学预防和治疗可能会限制XDR-GNB感染的频率和重症监护病房住院时间,并可能改善LT受体的结局。